![IGF-1 DES (Insulin-Like Growth Factor-1 DES [1-3]) 50mg](https://peptidechemical.net/wp-content/uploads/2025/12/IGD-300x300.png)
IGF-1 DES (Insulin-Like Growth Factor-1 DES [1-3])
IGF-1 DES is a truncated synthetic analog of insulin-like growth factor-1 (IGF-1) designed for research into receptor-mediated cellular signaling and growth factor pathways. This peptide consists of the first three amino acids of IGF-1, offering a targeted approach for studying receptor interactions with enhanced binding specificity.
In laboratory research, IGF-1 DES is valued for its selective interaction with IGF-1 receptors, which are widely expressed in multiple tissue types. Its truncated structure allows researchers to examine receptor activation and downstream intracellular signaling without the complexity of the full-length molecule.
One of the defining characteristics of IGF-1 DES is its ability to stimulate localized receptor pathways. This property makes it a useful tool for investigating short-term receptor engagement, signal transduction, and cellular response dynamics in controlled experimental models.
IGF-1 DES is frequently included in studies focused on tissue-specific growth signaling, receptor kinetics, and anabolic pathways. Researchers explore how targeted receptor activation influences transcriptional regulation, protein synthesis, and cellular adaptation.
The peptide is also used in comparative research alongside full-length IGF-1 and other analogs to study differences in receptor affinity, binding efficiency, and signal intensity. These analyses provide valuable insight into structure–activity relationships within the IGF-1 family of peptides.
IGF-1 DES’s compact structure enhances molecular stability, allowing predictable behavior in laboratory conditions. This stability is critical for reproducible results across multiple experimental setups.
Researchers often employ IGF-1 DES to investigate receptor-specific mechanisms in growth factor biology, intracellular signaling modulation, and localized cellular response.
Unlike broader-acting growth factors, IGF-1 DES operates through targeted receptor engagement, offering a focused model for understanding peptide-mediated signaling pathways without inducing widespread systemic effects.
The peptide is also studied for its effects on downstream intracellular pathways, including protein synthesis regulation and receptor-mediated transcriptional activity.
Because IGF-1 signaling intersects multiple cellular systems, IGF-1 DES is commonly used in systems-based research to examine integrated growth and metabolic signaling rather than isolated pathways.
Its well-characterized molecular profile makes IGF-1 DES a reliable research tool in cellular biology, receptor interaction studies, and peptide signaling investigations.
IGF-1 DES continues to attract scientific interest due to its specificity, stability, and utility in dissecting receptor-mediated mechanisms in laboratory research.
Its truncated design, predictable receptor engagement, and receptor-targeted signaling make IGF-1 DES an essential peptide for exploring IGF-1–related cellular communication and molecular biology pathways.
Description
Shipping & Delivery
Related products
AOD9604 6mg
AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 15mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157, TB-500, GHK-Cu (Glow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
Reviews
There are no reviews yet.